Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01883752 · ClinicalTrials.gov registry record · NA

Goal Directed Fluid Management Based on Non-invasive Monitoring

A NA study of Postoperative Complication, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
334
Enrollment target
1
Study location

NCT01883752 is a NA study of Postoperative Complication that has completed, run by University of California, Irvine. The registered enrollment target is 334 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01883752, a NA study of Postoperative Complication, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
334 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate whether goal directed fluid management using respiratory variations in the oxygen saturation by pulse oximetry (SpO2) waveform has potential to decrease postoperative complications and outcomes.

Conditions Studied

Interventions

  • PROCEDURE Goal-directed Therapy group

Study Locations (1)

California

  • University of California, Irvine Medical Center - Orange

Trial Details

FieldValue
Enrollment Target 334 participants
Start Date 2011-07
Est. Completion 2013-10
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT01883752

The ClinicalTrials.gov registry entry for NCT01883752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postoperative Complication appearing as the primary indexed condition, and to 1 intervention - of which Goal-directed Therapy group is the first listed.

NCT01883752 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01883752 about?

NCT01883752 is a clinical study titled "Goal Directed Fluid Management Based on Non-invasive Monitoring". The purpose of this study is to evaluate whether goal directed fluid management using respiratory variations in the oxygen saturation by pulse oximetry (SpO2) waveform has potential to decrease postoperative complications and outcomes.

What is the current status of trial NCT01883752?

This trial is currently completed. It is a NA study. The enrollment target is 334 participants. The study started on 2011-07. Estimated completion is 2013-10.

What conditions does trial NCT01883752 study?

This clinical trial studies the following conditions: Postoperative Complication.

What interventions are being tested in trial NCT01883752?

The interventions under investigation include: Goal-directed Therapy group (PROCEDURE).

Who is sponsoring clinical trial NCT01883752?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01883752 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.